Eli Lilly: Overvaluation Is A Big Red Flag (NYSE:LLY)

jetcityimage/iStock Editorial via Getty Images Investment thesis Eli Lilly’s (NYSE:LLY) stock is on fire after the massive success of its new drugs aimed at treating diabetes and obesity. The company has a stellar track record of success and will likely continue delivering strong results over the long term. However, my valuation analysis suggests that the…

Read More

Lincoln Electric: Overvaluation Is A Core Concern (NASDAQ:LECO)

Phynart Studio/E+ via Getty Images After previously covering Lincoln Electric (NASDAQ:LECO) with a hold rating, the stock has seen great price action, soaring to new highs. However, after examining the firm’s fundamentals and future expectations, I still believe that Lincoln Electric is currently overvalued, resulting in a hold. Business Overview Lincoln Electric Holdings, Inc. and…

Read More

Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation

skynesher/E+ via Getty Images Investment Thesis Charles River Laboratories (NYSE:CRL) operates in the lucrative and stable Diagnostics & Research sector for biopharmaceutical companies. The company was a remarkable outperformer, delivering impressive returns of 15% annually compounded over 21 years, reaching its zenith in 2021. However, this success was accompanied by substantial overvaluation, leading to a…

Read More